HOUSTON, September 15, 2023 (Newswire.com)
– Over the last few years, the landscape of plastic surgery has seen remarkable changes. Dr. Robert Kratschmer, a board-certified plastic surgeon based in Houston, sheds light on how the popularization of the drug Semaglutide is affecting patient choices in cosmetic procedures.
“Two years ago, liposuction and fat transfer were the procedures that dominated patient interest,” says Dr. Kratschmer. “While they remain popular, the rise of Semaglutide for weight management has led to a notable increase in other procedures, like panniculectomy, thigh lift, arm lift, and neck lift surgeries.”
Semaglutide, originally developed for the treatment of type 2 diabetes, has been growing in prominence for its off-label use in weight management. This has had ripple effects in the plastic surgery community.
Dr. Kratschmer explains, “Semaglutide has offered a non-surgical option for weight loss, which is changing the kinds of procedures people are seeking. Many of my patients have successfully used it for weight loss, but are then left with excess skin that they want to address. As a result, we’re seeing a considerable uptick in surgeries designed to remove excess skin and contour the body.”
This shift is significant, not only for prospective patients but also for the medical community at large. The rising interest in these procedures suggests that people are becoming increasingly conscious of comprehensive body transformations that focus on both weight loss and body contouring.
“Every medical advancement impacts patient choices,” Dr. Kratschmer says. “As physicians, we must adapt and continue to offer the best care based on emerging trends and technologies. It’s an exciting time in the field of plastic surgery, and I’m eager to see how this evolves in the years to come.”
For those considering plastic surgery, Dr. Kratschmer advises consultations to discuss individual needs and options. “Patient care is always our utmost priority. Our consultations aim to guide patients through the variety of choices now available, so they can make informed decisions that align with their goals,” he concludes.
To learn more about Dr. Robert Kratschmer and his practice, please visit SiliconeMD.com.
About Dr. Robert Kratschmer
Dr. Robert Kratschmer is a board-certified plastic surgeon with over 20 years of experience. Based in the Greater Houston area, he specializes in a wide range of cosmetic procedures and is committed to providing exceptional care for his patients.
Unveiling the Potential Breakthrough – Activating Stem Cells to Delay and Reduce Dementia and Depression Risk
Dr. Lee & Dr. Lin Dr. Jia-Fu Lee from Tzu Chi Hospital & Dr. Chai-Ching Lin from Power-Stem Biomedical
LOS ANGELES, September 14, 2023 (Newswire.com)
– Alzheimer’s disease and dementia severity in the United States is escalating, posing a growing public health crisis. With an aging population, millions are affected by these devastating conditions. The ratio of Alzheimer’s patients in the 65+ demographic has reached 1 in 9 based on the study by the American CDC (Center of Disease Control and Prevention), highlighting the urgent need for research, care improvements, and increased awareness to address their profound social, economic, and emotional impact.
“Our momentous achievement has arrived!” declared Dr. Chai-Ching Lin, President, Power-Stem Biomedical. “We proudly introduce the world’s first stem cell supplement, underwent by rigorous clinical trials and scientific validation. This marks an exciting breakthrough in regenerative supplements, a new chapter in our commitment to advancing science and improving lives.”
They assessed brain degeneration by measuring Alzheimer’s Disease Risk Index (ADRI) and CD34+ hematopoietic stem cell levels throughscientific and quantitative blood tests after the usage of CD34 NU-Signals. It has been observed that when individuals start to notice memory and cognitive decline, the number of stem cells in their bodies also decreases significantly. Clinically, early detection and prevention are possible through a healthy diet, quality sleep, and regular exercise. And refer to the study, activating autologous stem cells through stem cell nutrients can significantly reduce value of ADRI risk index and increase stem cell count.
Dr. Lee from Taipei Tzu Chi Hospital’s Dementia Care Center stated that by analyzing brain waves with ADRI technology, and evaluating the risk of dementia through blood tests, it is possible to objectively detect the levels of depression and dementia risk. Through personalized regenerative supplement, mental well-being, exercise, and quality sleep, one can regain cardiovascular and brain health vitality.
Dr. Lin has been researching the field of stem cells for many years, and she has contributed significantly to stem cell nutrition. She has published multiple patents, scientific journals, and books. Dr. Lin emphasizes the importance of paying attention to one’s “Health Deposit” after the age of 40. Therefore, tracking CD34+ hematopoietic stem cells, NK natural killer cells, and ADRI annually are crucial life indicators to better understand one’s hematopoietic capacity, immune system, and self-healing ability.
Dr. Lee added that, especially in the case of ADRI values, they should be improved to reach a score of 0. Maintaining a happy and contented mind is essential for effectively staying away from depression and dementia.
LOS ANGELES, September 14, 2023 (Newswire.com)
– Seasonshare, a trailblazing leader in the sports and entertainment industry, is thrilled to announce the update and launch of its innovative product, “Flex,” in collaboration with the Orlando Magic. “Flex” is set to reshape the way fans engage with their favorite live events by empowering them to create their own tailor-made ticket bundles, aligning perfectly with evolving consumer behavior in event ticket purchases.
In an era marked by dynamic shifts in consumer preferences, Seasonshare recognizes the need for flexibility and personalization in the world of live events. “Flex” addresses this demand by allowing fans to allocate pre-purchased account credit towards event tickets, providing them with the freedom to curate their own unique ticket packages for the Orlando Magic’s exciting games.
Key Features of Seasonshare’s “Flex” with the Orlando Magic: 1. Customized Ticket Bundles: “Flex” lets fans design their ideal game experiences. Whether it’s a series of home games, specific matchups, or an entire season, fans can now build their personalized ticket bundles effortlessly.
2.Account Credit Allocation: Seasonshare’s innovative platform enables fans to use their account credit towards ticket purchases, making it a hassle-free process that aligns with today’s on-the-go lifestyle.
3. Enhanced Fan Engagement: By giving fans more control over their game attendance, “Flex” fosters a deeper connection between fans and their beloved team, the Orlando Magic.
4. Effortless Ticket Management: The platform provides a user-friendly interface for fans to manage their ticket bundles, ensuring a seamless and stress-free experience from start to finish.
As the landscape of event ticket purchases continues to evolve, Seasonshare’s “Flex” meets the demand for flexibility and convenience that modern consumers seek. This groundbreaking product will not only redefine how fans engage with live events but also strengthen the bond between the Orlando Magic and its dedicated fan base.
“The Orlando Magic are delighted to expand on our partnership with Seasonshare to introduce ‘Flex,’ said Magic’s Executive Vice President of Sales and Operations, Chris D’Orso. “This product represents a significant step forward in providing our fans with a more personalized and convenient way to enjoy games. It’s a testament to the Magic’s commitment to delivering an exceptional fan experience.”
“Flex” is poised to revolutionize the way fans access and enjoy live sports and entertainment events, ushering in a new era of personalized ticketing. With the Orlando Magic as its launch partner, Seasonshare is set to create a lasting impact on the sports and entertainment industry.
For more information about Seasonshare’s “Flex” and to start creating your own personalized ticket bundles, visit https://seasonshare.com/products/flex
About Seasonshare: Seasonshare is a leading innovator in the sports and entertainment industry, dedicated to enhancing the fan experience through cutting-edge technology and personalized solutions. By leveraging the power of data and fan engagement, Seasonshare is reshaping the way fans connect with their favorite teams and events.
TRUMBULL, Conn., September 14, 2023 (Newswire.com)
– Saturday afternoons in autumn mean college sports and the return of amateur athletes to their fields, gyms and stadiums. Student-athletes can stay healthier, heal more easily from soft-tissue injuries, and return to their sport more quickly with ZetrOZ Systems‘ sustained acoustic medicine (sam®) technology, now covered by secondary insurance for many colleges.
On average, more than 200,000 athletes in major National Collegiate Athletic Association (NCAA) sports are injured every year, according to a five-year study published by the Centers for Disease Control and Prevention in 2015.
Researchers found high injury rates across many of the sports kicking off this fall. Among all sports, college football had the highest raw number of injuries – an estimated 47,199 over the five years. It also had one of the highest injury rates of all sports, with 9.2 athletes injured for every 1,000 athlete-exposures to potential injury (one athlete’s participation in one competition or one practice).
Women’s soccer had the next-highest injury rate among fall sports, with 8.4 injuries per 1,000 athlete-exposure. Among all sports, men’s wrestling had the highest injury rate, at 13.1 injuries per 1,000 athlete-exposures. Women’s gymnastics, at 10.4 injuries per 1,000 athlete exposures, had the greatest injury rate among women’s sports.
Almost one out of four athlete injuries required more than seven days of recuperation before the athlete could return to practice or competition. Nearly half (45%) of all injuries were sprains and strains, and of those injuries, about one in four required a week of recuperation.
ZetrOZ Systems’ sustained acoustic medicine (sam®) technology is proven to reduce the recovery period for those kinds of soft-tissue injuries. More than 40 clinical studies have shown that the ZetrOZ sam® X1 and 2.0 devices reduce pain and improve function without using invasive surgery or potentially addictive painkillers.
“We work with college athletic trainers nationwide, and we know that our sam® devices help heal athletes’ soft-tissue injuries more quickly and help players return to practices and games sooner,” said Dr. George K. Lewis, founder and CEO of ZetrOZ Systems.
A 2022 study, by authors that included three respected college athletic trainers, examined sam® usage by 239 healthcare providers for treating injuries to tendons and ligaments, joints, large muscle groups, and bone. They reported that sam® provided clinical improvement in under two weeks in more than two-thirds of cases (68.9%) and resulted in a 50% reduction in pain medication. The study concluded sam® is an “effective, safe, easy-to-use, noninvasive, comfortable, and versatile therapeutic for healing musculoskeletal injuries.”
In addition, a 2022 article published in Open Orthopedics Journal surveyed athletic trainers working in professional, collegiate, and military sports medicine to evaluate ZetrOZ’s sam® technology. The study found that sam® is a “fast, simple topical application yielding rapid healing without causing additional trauma to suffering athletes.” The study also included follow-up interviews with the athletic trainers. The researchers reported that “Candid input from professional athletic and military ATs shows a consensus that sam® is a superior healing technology.”
A 2015 level 4 clinical study by sports medicine experts at Ohio State University and Duke University found sustained acoustic medicine delivered via ZetrOZ’s sam® reduced pain and improved strength in patients’ medial/lateral elbow tendons and Achilles tendons.
Sustained acoustic medicine works by increasing blood vessel diameters to improve blood flow. That increases oxygenated hemoglobin at the therapy site and removes cytokine enzymes and cellular waste, resulting in more rapid healing and reduced pain.
ZetrOZ’s sam® devices are the only FDA-cleared wearable ultrasound units approved for daily use at home. ZetrOZ’s technology was developed, in part, with funding from the National Institute of Health, National Science Foundation, Department of Defense, and NASA. ZetrOZ Systems products are designed and manufactured in the United States and are protected by 46 U.S. patents.
ZetrOZ Systems is leading healing innovations in sports medicine, developing wearable bioelectronic devices for the delivery of sustained acoustic medicine (sam®). Researched and funded by the federal government, ZetrOZ is built on the proprietary medical technology of +46 patents and is the exclusive manufacturer and developer of the sam® product line, which is designed for the treatment of acute and chronic musculoskeletal conditions.